Nuvation Bio Inc
(NUVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -477,284 | -14,792 | -75,802 | -62,015 | -42,366 |
| Depreciation Amortization | 302 | 58 | 222 | 167 | 112 |
| Accounts receivable | -117 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -2,791 | 227 | 70 | 234 | 438 |
| Other Working Capital | -10,733 | -4,609 | 540 | 1,981 | 152 |
| Other Operating Activity | 437,597 | 3,414 | 6,971 | 6,663 | 4,849 |
| Operating Cash Flow | $-53,026 | $-15,702 | $-67,999 | $-52,970 | $-36,815 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 29,322 | 7,569 | 8,976 | -24,186 | -14,616 |
| PPE Investments | -27 | -27 | -55 | -56 | -34 |
| Net Acquisitions | 19,863 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -7,343 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $41,815 | $7,542 | $8,921 | $-24,242 | $-14,650 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 7,035 | N/A | N/A | N/A | N/A |
| Debt Repayment | -6,322 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 2,056 | 21 | 628 | 508 | 431 |
| Financing Cash Flow | $2,769 | $21 | $628 | $508 | $431 |
| Exchange Rate Effect | 78 | N/A | N/A | N/A | N/A |
| Beginning Cash Position | 42,649 | 42,649 | 101,099 | 101,099 | 101,099 |
| End Cash Position | 34,285 | 34,510 | 42,649 | 24,395 | 50,065 |
| Net Cash Flow | $-8,364 | $-8,139 | $-58,450 | $-76,704 | $-51,034 |
| Free Cash Flow | |||||
| Operating Cash Flow | -53,026 | -15,702 | -67,999 | -52,970 | -36,815 |
| Capital Expenditure | -27 | -27 | -69 | -56 | -34 |
| Free Cash Flow | -53,053 | -15,729 | -68,068 | -53,026 | -36,849 |